Ensysce Biosciences Inc expected to post a loss of $1.06 a share - Earnings Preview

Ensysce Biosciences

04/11/2023 01:10

* Ensysce Biosciences Inc  ENSC.OQ   ENSC.O  is expected
to show a
rise in quarterly revenue when it reports  results 
    * The La Jolla California-based  company is expected to
report  a
112.4% increase in revenue to $593.33 thousand from $279.35
thousand a year ago, according to the mean estimate from 3
analysts, based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Ensysce Biosciences
Inc
is for a loss of $1.06 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ensysce
Biosciences Inc is $16.3​, above​ its last closing price
of $0.99. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -2.50       -2.73      -0.98     Beat    64.1
 Mar. 31 2023  -5.44       -5.08      -2.08     Beat    59
 Dec. 31 2022  -30.85      -28.88     -18.24    Beat    36.8​
 Sep. 30 2022  -38.40      -38.40     -8.88     Beat    76.9
 ​​Jun.        -31.20      -40.80     -57.60    Missed  -41.2
 30 2022                                                
 Mar. 31 2022  -38.40      -38.40     -14.40    Beat    62.5​
 Dec. 31 2021  21.60       -4.80      -1.08     Missed  -2,150
                                      hundred           
 This summary was machine generated November 4 at 01:10 GMT.  All
figures in US dollars  unless otherwise stated